Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users (Q35009760)

5 August 2017

title

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users (English)

1 reference

5 August 2017

Suzanne K Vosburg

1 reference

5 August 2017

Jeanne M Manubay

1 reference

5 August 2017

Verena Metz

1 reference

5 August 2017

Jermaine D Jones

1 reference

5 August 2017

Sandra D Comer

1 reference

5 August 2017

Maria A Sullivan

1 reference

5 August 2017

Shanthi Mogali

series ordinal

1 reference

5 August 2017

publication date

25 July 2014

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

5 August 2017

page(s)

784-798

1 reference

Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

The subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Indicators of buprenorphine and methadone use and abuse: what do we know?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Buprenorphine use: the international experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Abuse of prescription buprenorphine, regulatory controls and the role of the primary physician.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Sublingual buprenorphine is effective in the treatment of chronic pain syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

French field experience with buprenorphine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Effects of buprenorphine/naloxone in opioid-dependent humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Injecting misuse of buprenorphine among French drug users

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Choice between money and intranasal heroin in morphine-maintained humans.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Buprenorphine and naloxone interactions in methadone maintenance patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Clinical pharmacology of buprenorphine: ceiling effects at high doses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

8 July 2018

Buprenorphine kinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Buprenorphine suppresses heroin use by heroin addicts

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Behavioral pharmacology of buprenorphine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

The systemic availability of buprenorphine administered by nasal spray

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Clinical pharmacology of narcotic antagonists

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users

8 July 2018

1 reference

Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans.

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of intranasal "snorted" heroin.

21 January 2018

1 reference

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

21 January 2018

1 reference

Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration

21 January 2018

1 reference

The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia

21 January 2018

1 reference

Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?

21 January 2018

1 reference

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

21 January 2018

1 reference

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

21 January 2018

1 reference

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

21 January 2018

1 reference

Misuse of buprenorphine maintenance treatment since introduction of its generic forms: OPPIDUM survey

21 January 2018

1 reference

Effects of sublingually given naloxone in opioid-dependent human volunteers

21 January 2018

1 reference

Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics

21 January 2018

1 reference

Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France

21 January 2018

1 reference

Effects of high-dose intravenous buprenorphine in experienced opioid abusers

21 January 2018

1 reference

Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France.

21 January 2018

1 reference

Tackling Subutex abuse in Singapore

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Abuse liability of buprenorphine--a study among experienced drug users

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Buprenorphine effects on human heroin self-administration: an operant analysis.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4305506

Two New Rating Scales for Opiate Withdrawal

26 October 2018

1 reference

Acute administration of buprenorphine in humans: partial agonist and blockade effects

21 January 2018

1 reference

12 December 2020

Comparison of buprenorphine and methadone effects on opiate self-administration in primates

1 reference

12 December 2020

Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine

1 reference

12 December 2020

Plasma concentrations of heroin and morphine-related metabolites after intranasal and intramuscular administration

1 reference

12 December 2020

The effects of buprenorphine in buprenorphine-maintained volunteers

1 reference

12 December 2020

Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons

1 reference

12 December 2020

Identifiers

DOI

10.1111/ADB.12163

1 reference

5 August 2017

1 reference

5 August 2017

1 reference